Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1911373
Max Phase: Preclinical
Molecular Formula: C8H12N2O5
Molecular Weight: 216.19
Molecule Type: Small molecule
Associated Items:
ID: ALA1911373
Max Phase: Preclinical
Molecular Formula: C8H12N2O5
Molecular Weight: 216.19
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)/C=C/C(=O)NC[C@H](N)C(=O)O
Standard InChI: InChI=1S/C8H12N2O5/c1-15-7(12)3-2-6(11)10-4-5(9)8(13)14/h2-3,5H,4,9H2,1H3,(H,10,11)(H,13,14)/b3-2+/t5-/m0/s1
Standard InChI Key: IXTGTEFAVXEHRV-HRJJCQLASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 216.19 | Molecular Weight (Monoisotopic): 216.0746 | AlogP: -1.76 | #Rotatable Bonds: 5 |
Polar Surface Area: 118.72 | Molecular Species: ZWITTERION | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.64 | CX Basic pKa: 8.50 | CX LogP: -3.61 | CX LogD: -3.64 |
Aromatic Rings: 0 | Heavy Atoms: 15 | QED Weighted: 0.37 | Np Likeness Score: 0.89 |
1. Qian Y, Ahmad M, Chen S, Gillespie P, Le N, Mennona F, Mischke S, So SS, Wang H, Burghardt C, Tannu S, Conde-Knape K, Kochan J, Bolin D.. (2011) Discovery of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors., 21 (21): [PMID:21958546] [10.1016/j.bmcl.2011.09.009] |
2. Pawlak D, Stolarska M, Wojciechowski M, Andruszkiewicz R.. (2015) Synthesis, anticandidal activity of N(3)-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic amide derivatives--novel inhibitors of glucosamine-6-phosphate synthase., 90 [PMID:25497131] [10.1016/j.ejmech.2014.12.007] |
3. Pawlak D, Schielmann M, Wojciechowski M, Andruszkiewicz R.. (2016) Synthesis and biological activity of novel ester derivatives of N(3)-(4-metoxyfumaroyl)-(S)-2,3-diaminopropanoic acid containing amide and keto function as inhibitors of glucosamine-6-phosphate synthase., 26 (15): [PMID:27324977] [10.1016/j.bmcl.2016.06.016] |
4. Liu W,Yuan L,Wang S. (2020) Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall., 63 (21.0): [PMID:32692166] [10.1021/acs.jmedchem.0c00748] |
Source(1):